ZA200710909B - Immunogenic composition - Google Patents
Immunogenic compositionInfo
- Publication number
- ZA200710909B ZA200710909B ZA200710909A ZA200710909A ZA200710909B ZA 200710909 B ZA200710909 B ZA 200710909B ZA 200710909 A ZA200710909 A ZA 200710909A ZA 200710909 A ZA200710909 A ZA 200710909A ZA 200710909 B ZA200710909 B ZA 200710909B
- Authority
- ZA
- South Africa
- Prior art keywords
- immunogenic composition
- immunogenic
- composition
- Prior art date
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0513069.5A GB0513069D0 (en) | 2005-06-27 | 2005-06-27 | Immunogenic composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200710909B true ZA200710909B (en) | 2009-04-29 |
Family
ID=34856207
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200710853A ZA200710853B (en) | 2005-06-27 | 2007-12-13 | Immunogenic composition |
| ZA200710909A ZA200710909B (en) | 2005-06-27 | 2007-12-14 | Immunogenic composition |
| ZA200711074A ZA200711074B (en) | 2005-06-27 | 2007-12-18 | Process for manufacturing vaccines |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200710853A ZA200710853B (en) | 2005-06-27 | 2007-12-13 | Immunogenic composition |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200711074A ZA200711074B (en) | 2005-06-27 | 2007-12-18 | Process for manufacturing vaccines |
Country Status (7)
| Country | Link |
|---|---|
| CN (4) | CN101208103B (en) |
| ES (1) | ES2367918T5 (en) |
| FR (1) | FR12C0060I2 (en) |
| GB (1) | GB0513069D0 (en) |
| NO (1) | NO2021022I1 (en) |
| UA (1) | UA97233C2 (en) |
| ZA (3) | ZA200710853B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2634405C2 (en) * | 2012-01-30 | 2017-10-26 | Серум Инститьют Оф Индия Лтд. | Immunogenic composition |
| NZ704490A (en) * | 2012-08-16 | 2017-07-28 | Pfizer | Glycoconjugation processes and compositions |
| LT3506935T (en) * | 2016-09-02 | 2024-04-25 | Sanofi Pasteur, Inc. | Neisseria meningitidis vaccine |
| ES2847947T3 (en) * | 2016-11-25 | 2021-08-04 | Glaxosmithkline Biologicals Sa | Native VMEn-antigen conjugates and their use |
| CN109879967A (en) * | 2017-12-15 | 2019-06-14 | 苏州和锐生物科技有限公司 | A kind of preparation method and application of acetylglucosamine conjugate |
| CN110251667A (en) * | 2018-05-11 | 2019-09-20 | 武汉博沃生物科技有限公司 | A kind of immune combination preparation and its preparation method and application |
| CN115819616A (en) * | 2021-07-28 | 2023-03-21 | 江苏瑞科生物技术股份有限公司 | Gene recombination VZV fusion protein and preparation method and application thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5180815A (en) * | 1988-04-13 | 1993-01-19 | Fuji Photo Film Co., Ltd. | Modified protein for carrying hapten |
| CZ20024224A3 (en) * | 2000-06-29 | 2003-05-14 | Glaxosmithkline Biologicals S. A. | Pharmaceutical preparation |
| US20030068324A1 (en) * | 2001-04-06 | 2003-04-10 | Jean-Michel Fournier | Conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid |
| GB0115176D0 (en) * | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
| CN1401328A (en) * | 2002-10-18 | 2003-03-12 | 北京绿竹生物技术有限责任公司 | Epidemic meningitis polyose-protein binding vaccine |
| CN101926988B (en) * | 2003-01-30 | 2014-06-04 | 诺华疫苗和诊断有限公司 | Injectable vaccines against multiple meningococcal serogroups |
-
2005
- 2005-06-27 GB GBGB0513069.5A patent/GB0513069D0/en not_active Ceased
-
2006
- 2006-06-23 CN CN2006800233344A patent/CN101208103B/en active Active
- 2006-06-23 CN CN200680023149.5A patent/CN101222935B/en active Active
- 2006-06-23 ES ES06754611.9T patent/ES2367918T5/en active Active
- 2006-06-23 CN CN2006800230577A patent/CN101208101B/en active Active
- 2006-06-23 UA UAA200714085A patent/UA97233C2/en unknown
- 2006-06-23 CN CN2006800311786A patent/CN101247827B/en active Active
-
2007
- 2007-12-13 ZA ZA200710853A patent/ZA200710853B/en unknown
- 2007-12-14 ZA ZA200710909A patent/ZA200710909B/en unknown
- 2007-12-18 ZA ZA200711074A patent/ZA200711074B/en unknown
-
2012
- 2012-10-18 FR FR12C0060C patent/FR12C0060I2/en active Active
-
2021
- 2021-05-25 NO NO2021022C patent/NO2021022I1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101208103A (en) | 2008-06-25 |
| GB0513069D0 (en) | 2005-08-03 |
| CN101208101B (en) | 2013-01-02 |
| NO2021022I1 (en) | 2021-05-25 |
| CN101208101A (en) | 2008-06-25 |
| FR12C0060I2 (en) | 2017-01-06 |
| FR12C0060I1 (en) | 2012-12-14 |
| CN101208103B (en) | 2013-04-24 |
| UA97233C2 (en) | 2012-01-25 |
| ES2367918T5 (en) | 2014-11-21 |
| ZA200711074B (en) | 2009-07-29 |
| ZA200710853B (en) | 2009-04-29 |
| CN101247827A (en) | 2008-08-20 |
| CN101222935B (en) | 2015-07-29 |
| ES2367918T3 (en) | 2011-11-10 |
| CN101222935A (en) | 2008-07-16 |
| CN101247827B (en) | 2013-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2200002I1 (en) | Immunogenic composition | |
| IL181825A0 (en) | Immunogenic composition | |
| IL186828A0 (en) | Vaccine composition | |
| GB0526038D0 (en) | Immunogenic composition | |
| ZA200710909B (en) | Immunogenic composition | |
| GB0606416D0 (en) | Immunogenic composition | |
| GB0421079D0 (en) | Immunogenic composition | |
| ZA200710854B (en) | Immunogenic composition | |
| GB0524204D0 (en) | Immunogenic composition | |
| GB0503143D0 (en) | Immunogenic composition | |
| GB0515556D0 (en) | Immunogenic composition | |
| GB0526040D0 (en) | Immunogenic composition | |
| GB0526041D0 (en) | Immunogenic composition | |
| GB0502569D0 (en) | Vaccine composition | |
| GB0421081D0 (en) | Immunogenic composition | |
| GB0421078D0 (en) | Immunogenic composition | |
| GB0421082D0 (en) | Immunogenic composition |